Verve Ventures logo

Verve Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

6

Common Fundraising Type

Equity

Metafuels logo
Metafuels

Sustainable Aviation Fuel

Metafuels is a Swiss-based company specializing in the production of sustainable aviation fuel through a proprietary technology that converts green methanol into a synthetic jet fuel substitute, aiming to reduce lifecycle emissions by up to 90% without requiring modifications to existing aviation infrastructure.

Equity
$14M
01/15/2025
Article
Phlair logo
Phlair

Direct Air Capture

Verve Ventures logo
UnternehmerTUM Funding for Innovators logo
Planet A logo
Counteract logo
Exantia Capital logo
Atlantic Labs logo
EU logo

Phlair is a Munich-based startup developing hydrolyzer-based Direct Air Capture (DAC) technology to reduce CO2 capture costs and scale up carbon capture plants.

Seed
$16.1M
09/19/2024
Article
Neo Medical logo
Neo Medical

Spine surgery

Neo Medical SA is a Swiss technology company that develops innovative spine surgery technologies and an AI-driven augmented reality platform for surgical procedures.

Series B
$68.6M
09/17/2024
Article

Memo Therapeutics is a late-stage biotech company that has raised CHF 25M in a Series C funding round to develop its antibody, AntiBKV, and advance its existing antibody pipeline.

Series C
$27.6M
11/02/2023
Article
Poppins logo
Poppins

Healthtech

Verve Ventures logo
Kurma Partners logo
HEC Ventures logo
Eurazeo logo
Bpifrance logo
BNP Paribas Développement logo
Allianz France logo

Poppins develops digital therapeutic musical video games for children with neurodevelopmental disorders, such as dyslexia and dyscalculia, and has raised €8 million in funding to expand their program and support further research.

Equity
$8.4M
10/18/2023
Article
Orakl Oncology logo
Orakl Oncology

Precision Oncology

Verve Ventures logo
Speedinvest logo
HCVC logo

Orakl Oncology develops a techbio platform that combines biology with patient data to create unique tumor avatars, helping pharma and biotech companies identify new therapeutic targets and increase clinical trial success rates.

Equity
$3.1M
10/04/2023
Article